The Efficacy of a New Long-Acting Injectable PrEP
The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.
This week marked what may be the final death knell for USAID and for much of the U.S. government’s decades-long investment in global health and development, an unparalleled effort that has helped to save millions of lives around the world.
This fact sheet explores the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government's major global initiative to combat HIV/AIDS.
Jennifer Kates, Senior Vice President and Director of KFF’s Global Health & HIV Policy program, testified before the U.S. House of Representatives’ Committee on Foreign Affairs as part of a hearing on Unique Challenges Women Face in Global Health. Her testimony describes the role of the U.S. government in women’s global health and highlights challenges and opportunities to strengthen these efforts.
With ongoing questions about future U.S. support for multilateral health efforts as well as important markers on the near horizon, including donor replenishment conferences for both the Global Fund and Gavi within the next two years, this brief highlights five key facts about U.S. engagement with multilateral global health organizations.
Includes PEPFAR’s original authorizing legislation, as well as each subsequent reauthorization legislation.
Includes all of PEPFAR’s multi-year strategies, as well as related documents.
The COP/ROP guidance underpins the development of annual plans by both bilateral and regional PEPFAR programs.
This issue brief assesses how the HIV policy landscapes in PEPFAR countries compare to international standards and recommendations. Additionally, we look at the HIV policy landscapes in PEPFAR countries as compared to peer countries. These comparisons are done at the overall, category, and policy indicator level.
The COVID-19 has exacted a significant toll on the global economy. This new analysis looks at the economic impacts in PEPFAR countries finding that these countries generally fared worse than their economic and regional peers. In addition, the projected economic growth in these countries remains below pre-pandemic levels.
© 2026 KFF